Search

Your search keyword '"Wei-Kai Wu"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Wei-Kai Wu" Remove constraint Author: "Wei-Kai Wu"
101 results on '"Wei-Kai Wu"'

Search Results

1. Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients

2. Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice

Catalog

Books, media, physical & digital resources

3. Bifidobacterium alleviate metabolic disorders via converting methionine to 5’-methylthioadenosine

4. Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice

5. Healthy diet intervention reverses the progression of NASH through gut microbiota modulation

6. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

7. Ginger essential oil and citral ameliorates atherosclerosis in ApoE−/− mice by modulating trimethylamine-N-oxide and gut microbiota

8. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases

9. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation

11. Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition

12. Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles

13. Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery

14. Optimization of fecal sample processing for microbiome study — The journey from bathroom to bench

15. Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies

16. Mining Gut Microbiota From Bariatric Surgery for MAFLD

17. A Novel Insight at Atherogenesis: The Role of Microbiome

18. Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy

19. Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis

20. Autophagy and Mitophagy as Essential Components of Atherosclerosis

21. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection

22. Clinical Effectiveness of a Combination of Black Elder Berries, Violet Herb, and Calendula Flowers in Chronic Obstructive Pulmonary Disease: The Results of a Double-Blinded Placebo-Controlled Study

23. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis

24. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment

25. Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study

26. Contribution of Neurotrophins to the Immune System Regulation and Possible Connection to Alcohol Addiction

27. Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota

28. Impact of Esophageal Motility on Microbiome Alterations in Symptomatic Gastroesophageal Reflux Disease Patients With Negative Endoscopy: Exploring the Role of Ineffective Esophageal Motility and Contraction Reserve.

29. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass

30. Reassessing the safety of dietary emulsifiers through the lens of gut microbiota

31. Ginger essential oil and citral ameliorate atherosclerosis via modulating TMAO and gut microbiota in ApoE−/− mice fed on Gubra amylin NASH diet with ʟ-carnitine

32. Ginger essential oil prevents NASH progression by blockading the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway

33. Establishment of animal models for NASH and utilization for mining associated gut microbiota

34. Probiotic

35. Development of an Efficient and Sensitive Chemical Derivatization-Based LC–MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease

36. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer

38. Palm oil-containing high-fat diet with LPS and CCl4 C57BL/6J mouse model induces the progression of NASH/liver fibrosis and remodels the gut microbiota and its function

39. Anti-depressive-like and cognitive impairment alleviation effects of Gastrodia elata Blume water extract is related to gut microbiome remodeling in ApoE

40. Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles

41. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice

42. Gastrodia Elata Blume Water Extract Induces Alterations in Gut Microbiome Related to Anti-Depression Effect and Cognition Improvement in Apoe −/− Mice Exposed to Unpredictable Chronic Mild Stress

43. Ginger Essential Oil and Citral Ameliorate Atherosclerosis Via Modulating TMAO and Gut Microbiota in ApoE −/− Mice Fed on Gubra Amylin NASH Diet with ʟ-Carnitine

45. Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition

46. Atherosclerosis Amelioration by Allicin in Raw Garlic through Gut Microbiota and Trimethylamine-N-Oxide Modulation

47. Probiotic Lactiplantibacillus plantarum Tana Isolated from an International Weightlifter Enhances Exercise Performance and Promotes Antifatigue Effects in Mice

48. Gastrodia elata Blume water extract modulates neurotransmitters and alters the gut microbiota in a mild social defeat stress-induced depression mouse model

49. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection

50. The role of sialic acids in the initiation of atherosclerosis